Effects of exenatide on microvascular reactivity in patients with type 2 diabetes and coronary artery disease: A randomized controlled study

ConclusionsThree months' daily treatment with the GLP ‐1RA exenatide in T2DM patients with CAD showed no significant effects on skin microvascular function or blood glucose control, while this study confirms a reduction in body weight and blood pressure by exenatide, as compared to conventional antidiabetic drug treatment.

Source: Microcirculation - March 1, 2021 Category: Research Authors: Nikolaos Östlund Papadogeorgos, Jeanette Kuhl, Angela Shore, Thomas Kahan, Gun Jörneskog, Majid Kalani Tags: ORIGINAL ARTICLE Source Type: research